Oral Inosine Does Not Slow Progression of Early Parkinson Disease
No significant difference seen in rate of clinical disease progression or in secondary efficacy outcomes versus placebo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.